Armata Pharmaceuticals (ARMP) Goodwill & Intangibles (2013 - 2026)

Armata Pharmaceuticals has reported Goodwill & Intangibles for 14 years, with the latest figure at $13.7 million in Q1 2026.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $13.7 million, changed 0.0% from the prior year.
• Goodwill & Intangibles was little changed at $13.7 million in Q1 2026 per ARMP's latest filing, from $13.7 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $13.7 million in Q1 2022 and troughed at $13.7 million in Q1 2022.
• A 5-year average of $13.7 million and a median of $13.7 million in 2022 frame the typical range for Goodwill & Intangibles.
• The widest YoY moves for Goodwill & Intangibles: up 0.0% in 2022, down 0.0% in 2022.
• Over 5 years, Goodwill & Intangibles stood at $13.7 million in 2022, then changed by 0.0% to $13.7 million in 2023, then changed by 0.0% to $13.7 million in 2024, then changed by 0.0% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $13.7 million, $13.7 million, and $13.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.